🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single institution study of combining decitabine with fludarabine...
Status
Completed
Location
Hackensack University Medical Center - John Theurer Cancer Center
Start Date
2009-05
Trial ID
NCT01455506
Treatments Being Tested
This study aims to determine whether the recurrence rate of high-risk acute...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2025-01-01
Trial ID
NCT07101588
Treatments Being Tested
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
Allo-HSCT is the most effective way to cure sAML patients. At present, the ...
Status
Unknown
Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Start Date
2022-07
Trial ID
NCT05449899
This clinical trial involves individuals who have been diagnosed with Acute...
Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2018-10-24
Trial ID
NCT03613532
Treatments Being Tested
Objectives: Primary Objectives: 1. To determine the safety and feasibilit...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2015-09-14
Trial ID
NCT02441803
The purpose of this study is to compare the efficacy and safety of venetocl...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-07-15
Trial ID
NCT07052422
Treatments Being Tested
The objective of this study is to describe the prevalence and prognostic im...
Status
Completed
Location
Hospital Israelita Albert Einstein
Start Date
2012-10
Trial ID
NCT02084563
Hematopoietic stem cell transplantation (HSCT) is the only curative option ...
Status
Unknown
Location
Multiple Locations
Start Date
2015-04-10
Trial ID
NCT03687463
Treatments Being Tested
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2024-06-18
Trial ID
NCT05564390
Treatments Being Tested